The long-read sequencing market size has grown exponentially in recent years. It will grow from $1.15 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 26.8%. The growth in the historic period can be attributed to limitations of short-read sequencing, growth of genomics research, technological breakthroughs in nanopore sequencing, demand for accurate genome assembly, increased funding in life sciences.
The long-read sequencing market size is expected to see exponential growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 26.5%. The growth in the forecast period can be attributed to clinical adoption of long-read sequencing, declining sequencing costs, integration with AI-based analysis, expansion in oncology diagnostics, growth of population genomics. Major trends in the forecast period include increasing adoption of long-read technologies, improved structural variant detection, growth of hybrid sequencing approaches, expansion of rare disease genomics, rising use in complex genome assembly.
The rising incidence of genetic disorders is anticipated to drive the expansion of the long-read sequencing market in the coming years. Genetic disorders are conditions caused by alterations or mutations in DNA, which can be inherited or occur spontaneously, impacting health, development, or bodily functions. The growing incidence of genetic disorders is attributed to heightened awareness and advances in diagnostic technologies, which allow for earlier and more precise identification of previously undiagnosed conditions. Long-read sequencing supports the management of genetic disorders by delivering highly accurate and comprehensive genomic insights, making it particularly suitable for diagnosing complex and rare conditions. It minimizes diagnostic uncertainty by identifying structural variations and intricate mutations, enhancing personalized treatment and clinical decision-making. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based national charity, reported that the number of people living with cystic fibrosis (CF) in the UK increased from 11,148 in 2022 to 11,318 in 2023. Consequently, the rising incidence of genetic disorders is propelling the growth of the long-read sequencing market.
Leading companies in the long-read sequencing market are focusing on developing innovative solutions such as HiFi reads to improve sequencing accuracy, detect complex genetic variations, and accelerate genomic research. High-fidelity (HiFi) reads are long DNA sequences generated by advanced long-read sequencing technologies, offering both extended read lengths and extremely low error rates. This enables accurate detection of complex genetic variants and structural variations. For instance, in November 2024, Pacific Biosciences of California Inc. launched the Vega system, its first benchtop long-read sequencing platform. The Vega system provides highly accurate HiFi data with 99.9% read accuracy and enables faster, more accessible genomic analysis. This compact, affordable sequencer supports applications such as RNA sequencing, targeted sequencing, and small genome sequencing, bringing advanced genomics capabilities to more laboratories. The system simplifies workflows with onboard computing and user-friendly operation, helping researchers efficiently unlock complex genetic insights.
In March 2024, Clinical Microbiomics A/S, a Denmark-based multi-omics microbiome company, acquired DNASense ApS for an undisclosed sum. With this acquisition, Clinical Microbiomics aims to enhance its long-read sequencing capabilities for metagenomics, industrial, and environmental microbiome applications by incorporating DNASense’s advanced long-read DNA and RNA sequencing technologies and high-resolution bioinformatics. DNASense ApS is a Denmark-based contract research organization (CRO) that specializes in long-read sequencing services and analytical workflows for DNA and RNA.
Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG.
North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the long-read sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs of sequencing instruments, flow cells, and specialized consumables used in long-read sequencing. Asia-Pacific suppliers heavily impact global availability, particularly for nanopore and SMRT platforms. These costs have slowed adoption in research institutes. Positively, tariffs are encouraging regional manufacturing, platform innovation, and supply chain diversification.
The long-read sequencing market research report is one of a series of new reports that provides long-read sequencing market statistics, including long-read sequencing industry global market size, regional shares, competitors with a long-read sequencing market share, detailed long-read sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the long-read sequencing industry. This long-read sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Long-read sequencing refers to a deoxyribonucleic acid or ribonucleic acid sequencing method that produces relatively long continuous reads of nucleic acids, often ranging from thousands to millions of base pairs, compared to short-read techniques. It allows for more precise genome assembly, identification of structural variations, and analysis of complex genomic regions.
The main product and service categories of long-read sequencing are instruments or platforms, consumables and reagents, and services and software. Instruments or platforms refer to the sequencing devices and hardware used to conduct long-read sequencing. This includes workflows such as pre-sequencing, sequencing, and data analysis, and is supported by technology platforms including single molecule real-time (SMRT) high-fidelity (HiFi) sequencing, nanopore sequencing, synthetic long-read or linked-read, hybrid, and others. It is applied in human genomics and rare-disease diagnostics, oncology and liquid biopsy, metagenomics and microbiome, transcriptomics, agri-genomics and plant or animal breeding, and others, serving end users such as academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.
The long-read sequencing market consists of revenues earned by entities by providing services such as high-throughput DNA sequencing, real-time genome analysis, structural variant detection, and de novo genome assembly. The market value includes the value of related goods sold by the service provider or included within the service offering. The long-read sequencing market also includes sales of library preparation kits, analysis tools, and library and sample prep kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The long-read sequencing market size is expected to see exponential growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 26.5%. The growth in the forecast period can be attributed to clinical adoption of long-read sequencing, declining sequencing costs, integration with AI-based analysis, expansion in oncology diagnostics, growth of population genomics. Major trends in the forecast period include increasing adoption of long-read technologies, improved structural variant detection, growth of hybrid sequencing approaches, expansion of rare disease genomics, rising use in complex genome assembly.
The rising incidence of genetic disorders is anticipated to drive the expansion of the long-read sequencing market in the coming years. Genetic disorders are conditions caused by alterations or mutations in DNA, which can be inherited or occur spontaneously, impacting health, development, or bodily functions. The growing incidence of genetic disorders is attributed to heightened awareness and advances in diagnostic technologies, which allow for earlier and more precise identification of previously undiagnosed conditions. Long-read sequencing supports the management of genetic disorders by delivering highly accurate and comprehensive genomic insights, making it particularly suitable for diagnosing complex and rare conditions. It minimizes diagnostic uncertainty by identifying structural variations and intricate mutations, enhancing personalized treatment and clinical decision-making. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based national charity, reported that the number of people living with cystic fibrosis (CF) in the UK increased from 11,148 in 2022 to 11,318 in 2023. Consequently, the rising incidence of genetic disorders is propelling the growth of the long-read sequencing market.
Leading companies in the long-read sequencing market are focusing on developing innovative solutions such as HiFi reads to improve sequencing accuracy, detect complex genetic variations, and accelerate genomic research. High-fidelity (HiFi) reads are long DNA sequences generated by advanced long-read sequencing technologies, offering both extended read lengths and extremely low error rates. This enables accurate detection of complex genetic variants and structural variations. For instance, in November 2024, Pacific Biosciences of California Inc. launched the Vega system, its first benchtop long-read sequencing platform. The Vega system provides highly accurate HiFi data with 99.9% read accuracy and enables faster, more accessible genomic analysis. This compact, affordable sequencer supports applications such as RNA sequencing, targeted sequencing, and small genome sequencing, bringing advanced genomics capabilities to more laboratories. The system simplifies workflows with onboard computing and user-friendly operation, helping researchers efficiently unlock complex genetic insights.
In March 2024, Clinical Microbiomics A/S, a Denmark-based multi-omics microbiome company, acquired DNASense ApS for an undisclosed sum. With this acquisition, Clinical Microbiomics aims to enhance its long-read sequencing capabilities for metagenomics, industrial, and environmental microbiome applications by incorporating DNASense’s advanced long-read DNA and RNA sequencing technologies and high-resolution bioinformatics. DNASense ApS is a Denmark-based contract research organization (CRO) that specializes in long-read sequencing services and analytical workflows for DNA and RNA.
Major companies operating in the long-read sequencing market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Roche Sequencing Solutions Inc., The Garvan Institute, Element Biosciences Inc., Eurofins Genomics, CD Genomics, BaseClear B.V, France Génomique, GrandOmics Biosciences Co. Ltd., Future Genomics Technologies B.V., MicrobesNG.
North America was the largest region in the long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the long-read sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs of sequencing instruments, flow cells, and specialized consumables used in long-read sequencing. Asia-Pacific suppliers heavily impact global availability, particularly for nanopore and SMRT platforms. These costs have slowed adoption in research institutes. Positively, tariffs are encouraging regional manufacturing, platform innovation, and supply chain diversification.
The long-read sequencing market research report is one of a series of new reports that provides long-read sequencing market statistics, including long-read sequencing industry global market size, regional shares, competitors with a long-read sequencing market share, detailed long-read sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the long-read sequencing industry. This long-read sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Long-read sequencing refers to a deoxyribonucleic acid or ribonucleic acid sequencing method that produces relatively long continuous reads of nucleic acids, often ranging from thousands to millions of base pairs, compared to short-read techniques. It allows for more precise genome assembly, identification of structural variations, and analysis of complex genomic regions.
The main product and service categories of long-read sequencing are instruments or platforms, consumables and reagents, and services and software. Instruments or platforms refer to the sequencing devices and hardware used to conduct long-read sequencing. This includes workflows such as pre-sequencing, sequencing, and data analysis, and is supported by technology platforms including single molecule real-time (SMRT) high-fidelity (HiFi) sequencing, nanopore sequencing, synthetic long-read or linked-read, hybrid, and others. It is applied in human genomics and rare-disease diagnostics, oncology and liquid biopsy, metagenomics and microbiome, transcriptomics, agri-genomics and plant or animal breeding, and others, serving end users such as academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.
The long-read sequencing market consists of revenues earned by entities by providing services such as high-throughput DNA sequencing, real-time genome analysis, structural variant detection, and de novo genome assembly. The market value includes the value of related goods sold by the service provider or included within the service offering. The long-read sequencing market also includes sales of library preparation kits, analysis tools, and library and sample prep kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Long-Read Sequencing Market Characteristics
3. Long-Read Sequencing Market Supply Chain Analysis
4. Global Long-Read Sequencing Market Trends and Strategies
5. Long-Read Sequencing Market Analysis of End Use Industries
7. Global Long-Read Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Long-Read Sequencing Total Addressable Market (TAM) Analysis for the Market
9. Long-Read Sequencing Market Segmentation
10. Long-Read Sequencing Market Regional and Country Analysis
11. Asia-Pacific Long-Read Sequencing Market
12. China Long-Read Sequencing Market
13. India Long-Read Sequencing Market
14. Japan Long-Read Sequencing Market
15. Australia Long-Read Sequencing Market
16. Indonesia Long-Read Sequencing Market
17. South Korea Long-Read Sequencing Market
18. Taiwan Long-Read Sequencing Market
19. South East Asia Long-Read Sequencing Market
20. Western Europe Long-Read Sequencing Market
21. UK Long-Read Sequencing Market
22. Germany Long-Read Sequencing Market
23. France Long-Read Sequencing Market
24. Italy Long-Read Sequencing Market
25. Spain Long-Read Sequencing Market
26. Eastern Europe Long-Read Sequencing Market
27. Russia Long-Read Sequencing Market
28. North America Long-Read Sequencing Market
29. USA Long-Read Sequencing Market
30. Canada Long-Read Sequencing Market
31. South America Long-Read Sequencing Market
32. Brazil Long-Read Sequencing Market
33. Middle East Long-Read Sequencing Market
34. Africa Long-Read Sequencing Market
36. Long-Read Sequencing Market Competitive Landscape and Company Profiles
37. Long-Read Sequencing Market Other Major and Innovative Companies
40. Long-Read Sequencing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Long-Read Sequencing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses long-read sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for long-read sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The long-read sequencing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product And Service: Instruments Or Platforms; Consumables And Reagents; Services And Software2) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
3) By Technology Platform: Single Molecule Real-Time (SMRT) High-Fidelity (HiFi) Sequencing; Synthetic Long-Read Or Linked-Read; Hybrid And Other Emerging
4) By Application: Human Genomics And Rare-Disease Diagnostics; Oncology And Liquid Biopsy; Metagenomics And Microbiome; Transcriptomics; Agri Genomics And Plant Or Animal Breeding; Other Applications
5) By End User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Uses
Subsegments:
1) By Instruments Or Platforms: Single-Molecule Real-Time (SMRT) Sequencers; Nanopore Sequencers2) By Consumables And Reagents: Library Preparation Kits; Sample Preparation Kits; Sequencing Kits
3) By Services And Software: Sequencing Services; Data Analysis Services; Bioinformatics Software
Companies Mentioned: Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Revvity Inc.; Bio-Rad Laboratories Inc.; BGI Genomics Co. Ltd.; Novogene Co. Ltd.; Takara Bio Inc.; Oxford Nanopore Technologies plc; Pacific Biosciences of California Inc.; New England Biolabs Inc.; Roche Sequencing Solutions Inc.; The Garvan Institute; Element Biosciences Inc.; Eurofins Genomics; CD Genomics; BaseClear B.V; France Génomique; GrandOmics Biosciences Co. Ltd.; Future Genomics Technologies B.V.; MicrobesNG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Long-Read Sequencing market report include:- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Revvity Inc.
- Bio-Rad Laboratories Inc.
- BGI Genomics Co. Ltd.
- Novogene Co. Ltd.
- Takara Bio Inc.
- Oxford Nanopore Technologies plc
- Pacific Biosciences of California Inc.
- New England Biolabs Inc.
- Roche Sequencing Solutions Inc.
- The Garvan Institute
- Element Biosciences Inc.
- Eurofins Genomics
- CD Genomics
- BaseClear B.V
- France Génomique
- GrandOmics Biosciences Co. Ltd.
- Future Genomics Technologies B.V.
- MicrobesNG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.46 Billion |
| Forecasted Market Value ( USD | $ 3.74 Billion |
| Compound Annual Growth Rate | 26.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
